Product Code: ETC8535443 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Companion Diagnostic Tests in Oncology Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Companion Diagnostic Tests in Oncology Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Companion Diagnostic Tests in Oncology Market - Industry Life Cycle |
3.4 Netherlands Companion Diagnostic Tests in Oncology Market - Porter's Five Forces |
3.5 Netherlands Companion Diagnostic Tests in Oncology Market Revenues & Volume Share, By Detection Technique, 2021 & 2031F |
3.6 Netherlands Companion Diagnostic Tests in Oncology Market Revenues & Volume Share, By Biomarker, 2021 & 2031F |
3.7 Netherlands Companion Diagnostic Tests in Oncology Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.8 Netherlands Companion Diagnostic Tests in Oncology Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Netherlands Companion Diagnostic Tests in Oncology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in the Netherlands |
4.2.2 Growing demand for personalized medicine and targeted therapies |
4.2.3 Technological advancements in companion diagnostic tests |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for companion diagnostic tests |
4.3.2 High cost associated with developing and implementing companion diagnostic tests |
4.3.3 Limited reimbursement policies for companion diagnostic tests |
5 Netherlands Companion Diagnostic Tests in Oncology Market Trends |
6 Netherlands Companion Diagnostic Tests in Oncology Market, By Types |
6.1 Netherlands Companion Diagnostic Tests in Oncology Market, By Detection Technique |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Detection Technique, 2021- 2031F |
6.1.3 Netherlands Companion Diagnostic Tests in Oncology Market Revenues & Volume, By DNA Detection, 2021- 2031F |
6.1.4 Netherlands Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Netherlands Companion Diagnostic Tests in Oncology Market, By Biomarker |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Companion Diagnostic Tests in Oncology Market Revenues & Volume, By EGFR, 2021- 2031F |
6.2.3 Netherlands Companion Diagnostic Tests in Oncology Market Revenues & Volume, By KRAS, 2021- 2031F |
6.2.4 Netherlands Companion Diagnostic Tests in Oncology Market Revenues & Volume, By HER2, 2021- 2031F |
6.2.5 Netherlands Companion Diagnostic Tests in Oncology Market Revenues & Volume, By BRAF V600E, 2021- 2031F |
6.2.6 Netherlands Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Netherlands Companion Diagnostic Tests in Oncology Market, By Cancer Type |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.3.3 Netherlands Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.3.4 Netherlands Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.3.5 Netherlands Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Liver Cancer, 2021- 2031F |
6.3.6 Netherlands Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Melanoma, 2021- 2031F |
6.3.7 Netherlands Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Netherlands Companion Diagnostic Tests in Oncology Market, By End-user |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Netherlands Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Netherlands Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Diagnostic Labs, 2021- 2031F |
6.4.5 Netherlands Companion Diagnostic Tests in Oncology Market Revenues & Volume, By Others, 2021- 2031F |
7 Netherlands Companion Diagnostic Tests in Oncology Market Import-Export Trade Statistics |
7.1 Netherlands Companion Diagnostic Tests in Oncology Market Export to Major Countries |
7.2 Netherlands Companion Diagnostic Tests in Oncology Market Imports from Major Countries |
8 Netherlands Companion Diagnostic Tests in Oncology Market Key Performance Indicators |
8.1 Adoption rate of companion diagnostic tests in oncology |
8.2 Number of partnerships and collaborations for companion diagnostic test development |
8.3 Rate of incorporation of companion diagnostic tests in treatment decision-making |
8.4 Patient outcomes improvement due to the use of companion diagnostic tests |
8.5 Time to market for new companion diagnostic tests |
9 Netherlands Companion Diagnostic Tests in Oncology Market - Opportunity Assessment |
9.1 Netherlands Companion Diagnostic Tests in Oncology Market Opportunity Assessment, By Detection Technique, 2021 & 2031F |
9.2 Netherlands Companion Diagnostic Tests in Oncology Market Opportunity Assessment, By Biomarker, 2021 & 2031F |
9.3 Netherlands Companion Diagnostic Tests in Oncology Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.4 Netherlands Companion Diagnostic Tests in Oncology Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Netherlands Companion Diagnostic Tests in Oncology Market - Competitive Landscape |
10.1 Netherlands Companion Diagnostic Tests in Oncology Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Companion Diagnostic Tests in Oncology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |